Antibe Therapeutics Stock Buy Hold or Sell Recommendation
| ATBPF Stock | USD 0.22 0.00 0.00% |
Assuming the 90 days horizon and your above-average risk tolerance, our recommendation regarding Antibe Therapeutics is 'Strong Sell'. Macroaxis provides Antibe Therapeutics buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding ATBPF positions. The advice algorithm takes into account all of Antibe Therapeutics' available fundamental, technical, and predictive indicators you will find on this site. Key drivers impacting Antibe Therapeutics' buy or sell advice are summarized below:
Real Value 0.21 | Hype Value 0.22 | Market Value 0.22 |
A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell Antibe Therapeutics given historical horizon and risk tolerance towards Antibe Therapeutics. When Macroaxis issues a 'buy' or 'sell' recommendation for Antibe Therapeutics, the advice is generated through an automated system that utilizes algorithms and statistical models.
Antibe |
Execute Antibe Therapeutics Buy or Sell Advice
The Antibe recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Antibe Therapeutics. Macroaxis does not own or have any residual interests in Antibe Therapeutics or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Antibe Therapeutics' advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Sell
Market Performance | Very Weak | Details | |
Volatility | Out of control | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Low | Details | |
Economic Sensitivity | Responds to the market | Details | |
Analyst Consensus | Not Available | Details | |
Reporting Quality (M-Score) | Inapplicable | Details |
Antibe Therapeutics Trading Alerts and Improvement Suggestions
| Antibe Therapeutics generated a negative expected return over the last 90 days | |
| Antibe Therapeutics has high historical volatility and very poor performance | |
| Antibe Therapeutics has some characteristics of a very speculative penny stock | |
| Net Loss for the year was (25.06 M) with profit before overhead, payroll, taxes, and interest of 3.55 M. | |
| Antibe Therapeutics has accumulated about 50.19 M in cash with (16.92 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.96, which can makes it an attractive takeover target, given it will continue generating positive cash flow. |
Antibe Therapeutics Returns Distribution Density
The distribution of Antibe Therapeutics' historical returns is an attempt to chart the uncertainty of Antibe Therapeutics' future price movements. The chart of the probability distribution of Antibe Therapeutics daily returns describes the distribution of returns around its average expected value. We use Antibe Therapeutics price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Antibe Therapeutics returns is essential to provide solid investment advice for Antibe Therapeutics.
| Mean Return | -0.88 | Value At Risk | -9.72 | Potential Upside | 10.53 | Standard Deviation | 11.89 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Antibe Therapeutics historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Antibe Therapeutics Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Antibe Therapeutics or Pharmaceuticals sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Antibe Therapeutics' price will be affected by overall pink sheet market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Antibe pink sheet's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over NYSE Composite | -0.96 | |
β | Beta against NYSE Composite | 1.21 | |
σ | Overall volatility | 12.17 | |
Ir | Information ratio | -0.08 |
Antibe Therapeutics Volatility Alert
Antibe Therapeutics is displaying above-average volatility over the selected time horizon. Antibe Therapeutics is a potential penny stock. Although Antibe Therapeutics may be in fact a good instrument to invest, many penny pink sheets are speculative in nature and are subject to artificial price hype. Please make sure you totally understand the upside potential and downside risk of investing in Antibe Therapeutics. We encourage investors to look for signals such as email spams, message board hypes, claims of breakthroughs, volume upswings, sudden news releases, promotions that are not reported, or demotions released before SEC filings. Please also check biographies and work history of current and past company officers before investing in high volatility instruments, penny stocks, or equities with microcap classification. You can indeed make money on Antibe instrument if you perfectly time your entry and exit. However, remember that penny pink sheets that have been the subject of artificial hype usually unable to maintain their increased share price for more than just a few days. The price of a promoted high volatility instrument will almost always revert back. The only way to increase shareholder value is through legitimate performance backed up by solid fundamentals.Antibe Therapeutics Fundamentals Vs Peers
Comparing Antibe Therapeutics' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Antibe Therapeutics' direct or indirect competition across all of the common fundamentals between Antibe Therapeutics and the related equities. This way, we can detect undervalued stocks with similar characteristics as Antibe Therapeutics or determine the pink sheets which would be an excellent addition to an existing portfolio. Peer analysis of Antibe Therapeutics' fundamental indicators could also be used in its relative valuation, which is a method of valuing Antibe Therapeutics by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Antibe Therapeutics to competition |
| Fundamentals | Antibe Therapeutics | Peer Average |
| Return On Equity | -0.4 | -0.31 |
| Return On Asset | -0.16 | -0.14 |
| Current Valuation | (19.98 M) | 16.62 B |
| Shares Outstanding | 52.14 M | 571.82 M |
| Shares Owned By Insiders | 7.79 % | 10.09 % |
| Price To Earning | (1.67) X | 28.72 X |
| Price To Book | 0.61 X | 9.51 X |
| Price To Sales | 2.96 X | 11.42 X |
| Gross Profit | 3.55 M | 27.38 B |
| EBITDA | (25.14 M) | 3.9 B |
| Net Income | (25.06 M) | 570.98 M |
| Cash And Equivalents | 50.19 M | 2.7 B |
| Cash Per Share | 0.96 X | 5.01 X |
| Total Debt | 205 K | 5.32 B |
| Debt To Equity | 0 % | 48.70 % |
| Current Ratio | 14.65 X | 2.16 X |
| Book Value Per Share | 0.90 X | 1.93 K |
| Cash Flow From Operations | (16.92 M) | 971.22 M |
| Earnings Per Share | (0.41) X | 3.12 X |
| Target Price | 4.53 | |
| Number Of Employees | 37 | 18.84 K |
| Beta | 0.0997 | -0.15 |
| Market Capitalization | 22.59 M | 19.03 B |
| Total Asset | 89.16 M | 29.47 B |
| Retained Earnings | (12.08 M) | 9.33 B |
| Working Capital | 1.45 M | 1.48 B |
| Current Asset | 3.96 M | 9.34 B |
| Current Liabilities | 2.51 M | 7.9 B |
| Z Score | 66.0 | 8.72 |
| Net Asset | 89.16 M |
Antibe Therapeutics Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Antibe . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Antibe Therapeutics Buy or Sell Advice
When is the right time to buy or sell Antibe Therapeutics? Buying financial instruments such as Antibe Pink Sheet isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Antibe Therapeutics in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Farming Thematic Idea Now
Farming
Companies producing farming products and providing services for farmers. The Farming theme has 40 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Farming Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Antibe Therapeutics Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.
Complementary Tools for Antibe Pink Sheet analysis
When running Antibe Therapeutics' price analysis, check to measure Antibe Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Antibe Therapeutics is operating at the current time. Most of Antibe Therapeutics' value examination focuses on studying past and present price action to predict the probability of Antibe Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Antibe Therapeutics' price. Additionally, you may evaluate how the addition of Antibe Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like |